# AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

> **NCT01154361** · PHASE2 · COMPLETED · sponsor: **Technical University of Munich**

## Conditions studied

- Angioedema

## Interventions

- **DRUG:** Icatibant (subcutaneous) and plazebo (intravenous)
- **DRUG:** Cortisone + Clemastin (intravenous) and plazebo (subcutaneous)

## Key facts

- **NCT ID:** NCT01154361
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154361, "AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01154361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*